JACC:亚硝酸盐能显著改善心衰患者的血液动力学状态水平

2017-07-09 MedSci MedSci原创

主动脉硬化和一氧化氮(NO)有效含量的减少是导致射血分数保留型心衰(HFpEF)的病理生理原因之一。近日,在国际心血管权威杂志JACC上发表了一篇旨在评估比较HFpEF患者和高血压对照组休息和运动时的动脉硬度指标,并确定无机亚硝酸盐能否缓解动脉硬化。本研究对22例高血压对照组和98例HFpEF患者进行了血液动力学测试,并对其呼出气体中的氧含量进行了检测。此外,通过将桡动脉压波形转换为中心动脉压对主

主动脉硬化和一氧化氮(NO)有效含量的减少是导致射血分数保留型心衰(HFpEF)的病理生理原因之一。近日,在国际心血管权威杂志JACC上发表了一篇旨在评估比较HFpEF患者和高血压对照组休息和运动时的动脉硬度指标,并确定无机亚硝酸盐能否缓解动脉硬化。

本研究对22例高血压对照组和98例HFpEF患者进行了血液动力学测试,并对其呼出气体中的氧含量进行了检测。此外,通过将桡动脉压波形转换为中心动脉压对主动脉负荷进行综合评估,包括动脉的顺应性、阻力、弹性和波反射。

研究结果表明,在静息状态下,HFpEF患者的动脉负荷和波反射与对照组无显着差异。在低于最大运动量期间,相比于对照组,HFpEF患者尽管有相似的平均动脉压力,但动脉顺应性显着降低,并且有更高的有效动脉弹性。这些结果与较高的心室充盈压力和降低的心输出量储备直接相关(p<0.0001)。在最大运动量下,相比于对照组,HFpEF患者具有更高的波反射、血管阻力和弹性,但是血管的顺应性更低。另外,有52例HFpEF患者接受了1:1的随机双盲亚硝酸钠和安慰剂的治疗,相比于安慰剂组,亚硝酸钠能显着降低患者静息状态下的波反射,并提高运动状态下的动脉顺应性、弹性和血液动力学水平。

射血分数保留型心衰患者的主动脉负荷是异常的,并与经典的血液动力学紊乱相关。此外,无机亚硝酸盐能缓解患者的动脉硬化,并改善血液动力学状态。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1990107, encodeId=f490199010e41, content=<a href='/topic/show?id=9d87892515b' target=_blank style='color:#2F92EE;'>#血液动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89251, encryptionId=9d87892515b, topicName=血液动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 13 03:04:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756251, encodeId=76651e5625188, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Wed Oct 04 09:04:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853685, encodeId=69271853685f0, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu May 17 11:04:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030538, encodeId=2ace203053815, content=<a href='/topic/show?id=a7b5242980f' target=_blank style='color:#2F92EE;'>#亚硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24298, encryptionId=a7b5242980f, topicName=亚硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Mon Feb 19 04:04:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325428, encodeId=914f132542868, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373348, encodeId=755413e3348d5, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220737, encodeId=608e220e37c3, content=如果能多介绍点就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:28:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220669, encodeId=92ed22066928, content=高血压能彻底治疗控制吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 10 09:44:39 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1990107, encodeId=f490199010e41, content=<a href='/topic/show?id=9d87892515b' target=_blank style='color:#2F92EE;'>#血液动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89251, encryptionId=9d87892515b, topicName=血液动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 13 03:04:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756251, encodeId=76651e5625188, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Wed Oct 04 09:04:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853685, encodeId=69271853685f0, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu May 17 11:04:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030538, encodeId=2ace203053815, content=<a href='/topic/show?id=a7b5242980f' target=_blank style='color:#2F92EE;'>#亚硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24298, encryptionId=a7b5242980f, topicName=亚硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Mon Feb 19 04:04:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325428, encodeId=914f132542868, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373348, encodeId=755413e3348d5, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220737, encodeId=608e220e37c3, content=如果能多介绍点就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:28:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220669, encodeId=92ed22066928, content=高血压能彻底治疗控制吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 10 09:44:39 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-10-04 paperyu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1990107, encodeId=f490199010e41, content=<a href='/topic/show?id=9d87892515b' target=_blank style='color:#2F92EE;'>#血液动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89251, encryptionId=9d87892515b, topicName=血液动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 13 03:04:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756251, encodeId=76651e5625188, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Wed Oct 04 09:04:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853685, encodeId=69271853685f0, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu May 17 11:04:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030538, encodeId=2ace203053815, content=<a href='/topic/show?id=a7b5242980f' target=_blank style='color:#2F92EE;'>#亚硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24298, encryptionId=a7b5242980f, topicName=亚硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Mon Feb 19 04:04:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325428, encodeId=914f132542868, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373348, encodeId=755413e3348d5, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220737, encodeId=608e220e37c3, content=如果能多介绍点就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:28:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220669, encodeId=92ed22066928, content=高血压能彻底治疗控制吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 10 09:44:39 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2018-05-17 hbwxf
  4. [GetPortalCommentsPageByObjectIdResponse(id=1990107, encodeId=f490199010e41, content=<a href='/topic/show?id=9d87892515b' target=_blank style='color:#2F92EE;'>#血液动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89251, encryptionId=9d87892515b, topicName=血液动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 13 03:04:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756251, encodeId=76651e5625188, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Wed Oct 04 09:04:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853685, encodeId=69271853685f0, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu May 17 11:04:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030538, encodeId=2ace203053815, content=<a href='/topic/show?id=a7b5242980f' target=_blank style='color:#2F92EE;'>#亚硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24298, encryptionId=a7b5242980f, topicName=亚硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Mon Feb 19 04:04:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325428, encodeId=914f132542868, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373348, encodeId=755413e3348d5, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220737, encodeId=608e220e37c3, content=如果能多介绍点就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:28:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220669, encodeId=92ed22066928, content=高血压能彻底治疗控制吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 10 09:44:39 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1990107, encodeId=f490199010e41, content=<a href='/topic/show?id=9d87892515b' target=_blank style='color:#2F92EE;'>#血液动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89251, encryptionId=9d87892515b, topicName=血液动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 13 03:04:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756251, encodeId=76651e5625188, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Wed Oct 04 09:04:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853685, encodeId=69271853685f0, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu May 17 11:04:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030538, encodeId=2ace203053815, content=<a href='/topic/show?id=a7b5242980f' target=_blank style='color:#2F92EE;'>#亚硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24298, encryptionId=a7b5242980f, topicName=亚硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Mon Feb 19 04:04:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325428, encodeId=914f132542868, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373348, encodeId=755413e3348d5, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220737, encodeId=608e220e37c3, content=如果能多介绍点就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:28:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220669, encodeId=92ed22066928, content=高血压能彻底治疗控制吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 10 09:44:39 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1990107, encodeId=f490199010e41, content=<a href='/topic/show?id=9d87892515b' target=_blank style='color:#2F92EE;'>#血液动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89251, encryptionId=9d87892515b, topicName=血液动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 13 03:04:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756251, encodeId=76651e5625188, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Wed Oct 04 09:04:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853685, encodeId=69271853685f0, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu May 17 11:04:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030538, encodeId=2ace203053815, content=<a href='/topic/show?id=a7b5242980f' target=_blank style='color:#2F92EE;'>#亚硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24298, encryptionId=a7b5242980f, topicName=亚硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Mon Feb 19 04:04:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325428, encodeId=914f132542868, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373348, encodeId=755413e3348d5, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220737, encodeId=608e220e37c3, content=如果能多介绍点就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:28:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220669, encodeId=92ed22066928, content=高血压能彻底治疗控制吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 10 09:44:39 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1990107, encodeId=f490199010e41, content=<a href='/topic/show?id=9d87892515b' target=_blank style='color:#2F92EE;'>#血液动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89251, encryptionId=9d87892515b, topicName=血液动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 13 03:04:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756251, encodeId=76651e5625188, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Wed Oct 04 09:04:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853685, encodeId=69271853685f0, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu May 17 11:04:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030538, encodeId=2ace203053815, content=<a href='/topic/show?id=a7b5242980f' target=_blank style='color:#2F92EE;'>#亚硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24298, encryptionId=a7b5242980f, topicName=亚硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Mon Feb 19 04:04:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325428, encodeId=914f132542868, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373348, encodeId=755413e3348d5, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220737, encodeId=608e220e37c3, content=如果能多介绍点就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:28:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220669, encodeId=92ed22066928, content=高血压能彻底治疗控制吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 10 09:44:39 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 zhangyou

    如果能多介绍点就更好了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1990107, encodeId=f490199010e41, content=<a href='/topic/show?id=9d87892515b' target=_blank style='color:#2F92EE;'>#血液动力学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89251, encryptionId=9d87892515b, topicName=血液动力学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 13 03:04:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756251, encodeId=76651e5625188, content=<a href='/topic/show?id=0249e354370' target=_blank style='color:#2F92EE;'>#硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73543, encryptionId=0249e354370, topicName=硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29e537091297, createdName=paperyu, createdTime=Wed Oct 04 09:04:00 CST 2017, time=2017-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853685, encodeId=69271853685f0, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu May 17 11:04:00 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030538, encodeId=2ace203053815, content=<a href='/topic/show?id=a7b5242980f' target=_blank style='color:#2F92EE;'>#亚硝酸盐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24298, encryptionId=a7b5242980f, topicName=亚硝酸盐)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Mon Feb 19 04:04:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325428, encodeId=914f132542868, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373348, encodeId=755413e3348d5, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Jul 11 07:04:00 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220737, encodeId=608e220e37c3, content=如果能多介绍点就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:28:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220669, encodeId=92ed22066928, content=高血压能彻底治疗控制吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 10 09:44:39 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 flysky120

    高血压能彻底治疗控制吗

    0

相关资讯

JAHA:克拉霉素联合免疫球蛋白可减少川崎病的复发率!

既往研究表明生物膜和机体的先天免疫在川崎病的发生中起到重要作用。近日,在国际心血管权威杂志JAHA上发表了一篇旨在探索抗生物膜药物-克拉霉素在川崎病治疗中的作用的临床研究。

Heart:魔都和帝都居民心血管病知识大比拼:七成以上居民不知道体力活动不足

北京和上海是中国人均寿命最长的两个城市,但近期有研究发现,北京和上海居民对心血管病危险因素的认识还存在很大的不足,尤其是不了解体力活动不足与心血管病的关系。

SCI REP:糖尿病患者的心血管长期风险预测–VILDIA评分!

由此可见,基于传统心血管危险因素和新的生物标志物的VILDIA评分要明显优于以前的风险算法。

JAMA:口服铁补充剂能改善心衰合并缺铁患者的运动能力?

2017年5月,发表在《JAMA》的一项由美国科学家进行的IRONOUT HF随机临床试验,发现口服铁补充剂对心衰合并射血分数降低和缺铁患者的运动能力无改善。

JACC:心血管疾病在女性中更应该引起重视

心血管疾病在美国是导致女性死亡的首要原因,然而却很少有女性意识到心血管疾病的重要性。甚至连内科医生对女性心血管疾病风险评估的意识都有待提高。近日,在国际心血管权威杂志JACC上发表了一篇妇女心脏联盟(WHA)2014年的全国性调查,旨在评估妇女和医生在心血管疾病方面存在的问题和有待改进的地方。 The Women’s Heart Alliance

杭州|CHINA STAR中青年‘科学家’培养计划临床研究培训第二场区域会隆重举行

7月1日,由中国心血管健康联盟、心血管健康(苏州工业园区)研究院共同发起的“CHINA STAR中青年‘科学家’ ”培养计划临床研究培训在杭州隆重举行,这是CHINA STAR项目的第二场区域会。此前已于6月17日在北京举行了第一场区域会。梅斯医学作为特邀媒体有幸共同参与和见证这两次会议。心血管疾病是全球健康的主要威胁;全球63%死亡来源于慢病,近一半为心血管疾病死亡。我国现有确诊慢病人群2.6亿